Streetbeat News

Revenues

DAWN

VIRX

Day One Biopharmaceuticals (DAWN) announced the sale of a Priority Review Voucher (PRV) for $108 million. As part of the transaction, $8.1 million will be paid to Viracta Therapeutics (VIRX) to satisfy PRV-related obligations under a license agreement.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2024 | 12:32 pm

ICLR

ICON has reaffirmed its FY24 revenue guidance of $8.48B-$8.72B and raised its FY24 EPS guidance to $14.75-$15.25. This represents a year-over-year revenue increase of 4.4% to 7.4% and an EPS increase of 15.3% to 19.2%.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2024 | 12:31 pm

SPY

Retail inventories excluding autos for April increased by 0.3%, compared to a decrease of 0.2% in the previous month.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2024 | 12:30 pm

SPY

The USA's initial jobless claims have risen to 219,000, slightly above the estimated 218,000 and the previous week's 216,000. This indicates a marginal increase in unemployment claims, which could have implications for the broader market.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2024 | 12:30 pm

SPY

The US GDP for Q1 grew by 1.3% quarter-over-quarter, falling short of the estimated 1.6% growth.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2024 | 12:30 pm

BBY

Best Buy (NYSE: BBY) reported Q1 adjusted EPS of $1.20, beating expectations, but missed on sales with $8.85 billion. The company faced a 6.8% decline in domestic revenue and incurred $15 million in restructuring charges. Despite challenges, CEO Corie Barry remains confident in strengthening positions in key categories. BBY shares rose 6.40% premarket.

Portfolio Pulse from Anusuya Lahiri

May 30, 2024 | 12:29 pm

RDFN

SPY

Redfin reports that 6.4% of home sellers cut their asking price for the four weeks ended May 26, indicating potential cooling in the housing market.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2024 | 12:20 pm

SNAL

Snail, Inc. (NASDAQ:SNAL) has launched the official e-commerce store for West Hunt on the Nintendo Switch platform, marking a significant milestone for the game.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2024 | 12:19 pm

TDSGF

Telo Genomics Corp (OTC:TDSGF) announced that its prognostic test for smoldering multiple myeloma, TeloViewSMM, has been accepted for publication in the American Journal of Hematology. The test demonstrated superior performance in predicting disease progression and stability compared to other oncology tests. The company recently announced a private placement to raise $2 million.

Portfolio Pulse from Vandana Singh

May 30, 2024 | 12:15 pm

NVEE

NV5 Global, Inc. (NVEE) has been awarded $14 million in contracts by utilities for geospatial asset and vegetation management services.

Portfolio Pulse from Benzinga Newsdesk

May 30, 2024 | 12:14 pm